Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BD08	GLUNORM M	G	Metformin HCl - 1000mg, Vildagliptin - 50mg		Tablet, film coated	1,089,856 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A10BD08	GLUNORM M	G	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,089,856 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
A10BF01	GLUFIX	G	Acarbose - 50mg	50mg	Tablet	1,294,120 L.L
A10BH02	GALVUS	B	Vildagliptin - 50mg	50mg	Tablet	950,097 L.L
A10BH02	GLUNORM	G	Vildagliptin - 50mg	50mg	Tablet	611,448 L.L
B01AC04	GREPID	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	1,297,770 L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg		Tablet, sugar coated, slow release	819,744 L.L
B05AA06	GELASPAN	B	Gelatine, succinylated - 4%	4%	Injectable solution	9,107,572 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
C05CA54	GINKOR FORT	B	Heptaminol HCl - 0.300g, Troxerutine - 0.300g, Ginkgo biloba extract - 0.014g		Capsule	681,328 L.L
C05CX	GINKGO BIOGARAN	G	Ginkgo biloba extract - 40mg	40mg	Tablet, coated	345,368 L.L
C05CX	GINKGO BIOGARAN	G	Ginkgo biloba extract - 40mg	40mg	Tablet, coated	985,037 L.L
C09CA04	GIZLAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	748,520 L.L
C09CA04	GIZLAN	G	Irbesartan - 300mg	300mg	Tablet, film coated	768,678 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	768,678 L.L
D01BA01	GRISEOFULVIN	G	Griseofulvin - 500mg	500mg	Tablet, scored	575,933 L.L
D02AX	GLYCERINE	G	Glycerol -		Liquid	163,821 L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
D07CC02	GENTACORT-FC	G	Fluocinolone acetonide - 0.01%, Clotrimazole - 1%, Gentamicin (sulfate) - 0.1%		Cream	302,365 L.L
G01AA51	GYNAMEND	G	Nystatin - 100,000IU, Neomycin (sulfate) - 35,000IU, Polymyxin B sulfate - 35,000IU		Capsule, soft	345,560 L.L
G01AF04	GYNO-MIKOZAL	G	Miconazole nitrate - 200mg	200mg	Ovule	503,941 L.L
G01AF04	GYNO-MIKOZAL	G	Miconazole nitrate - 400mg	400mg	Ovule	302,365 L.L